Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Retatrutide is not indicated for children, females who are pregnant or planning to become pregnant, or females who are breastfeeding, due to insufficient long-term safety data
planned for offering once legally available Expected weight loss: Early trials suggest potent effects, but long-term data still emerging Administration: Once-weekly injection (investigational) Best for: Future option for carefully selected patients under close medical supervision Not sure which is right for you
Initial improvements in hydration may appear within two weeks
Indian companies, including Dr
Retatrutide is a synthetic peptide classified as a triple-agonist , meaning it activates three different hormone receptors involved in metabolic regulation: GLP-1 (Glucagon-Like Peptide-1) GIP (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptors Most existing weight-loss research compounds focus on a single pathway, typically GLP-1
US$ 27.01
US$ 29.72
US$ 26.69
US$ 26.10
US$ 26.81
US$ 29.75
